Postmenopausal hormone therapy and the risk of cardiovascular disease: the epidemiologic evidence

Frank B Hu; Francine Grodstein

doi:10.1016/s0002-9149(01)02219-6

Related publications

Article2002

[Adverse cardiovascular effects of postmenopausal hormone replacement therapy].

Saskia Middeldorp, H.R. Büller, Jan P. Vandenbroucke, FM Helmerhorst, Frits R. Rosendaal

PubMed

Article2007

Coagulation Factors, Postmenopausal Hormone Replacement Therapy and the Risk of Venous Thrombosis: The WHI Clinical Trials of Postmenopausal Hormone Therapy.

Mary Cushman, Joseph C. Larson, Frits R. Rosendaal, Lawrence S. Phillips, Barbara V. Howard, J. David Curb, Jennifer Hays, Alison E. Baird, Charles B. Eaton, Susan R. Heckbert, Randall S. Stafford

Blood

Article2020

Metabolomic Effects of Hormone Therapy and Associations With Coronary Heart Disease Among Postmenopausal Women

Raji Balasubramanian, Olga Demler, Marta Guasch‐Ferré, Nina P. Paynter, Ryan Sheehan, Simin Liu, JoAnn E. Manson, Jordi Salas‐Salvadó, Miguel Ángel Martínez‐González, Frank B Hu, Clary B. Clish, Kathryn M. Rexrode

Letter2002

Hormone Replacement Therapy, Prothrombotic Mutations, and the Risk of Incident Nonfatal Ischemic Stroke in Postmenopausal Women

Rozenn N. Lemaître, Bruce M. Psaty, Susan R. Heckbert, Nicholas L. Smith, W. T. Longstreth, Frits R. Rosendaal

Arteriosclerosis Thrombosis and Vascular Biology

Article2001

Relationship Between Postmenopausal Hormone Replacement Therapy and Ovarian Cancer

Cristina Bosetti, Eva Negri, Silvia Franceschi, Dimitrios Trichopoulos, Valerie Beral, Carlo La Vecchia